About Symbios Technologies
Symbios Technologies is a company based in Fort Collins (United States) founded in 2008. Symbios Technologies offers products and services including Symbios Tubular Plasma Reactor and TPR4000. Symbios Technologies operates in a competitive market with competitors including Plasma Waters, AquaPure Technologies, WaterToken, Pellucid Water and PlasmaFluids, among others.
- Headquarter Fort Collins, United States
-
Sectors
Environment
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$500 K (USD), Grant
Jan 11, 2017
-
Investors
DOE
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Symbios Technologies
Symbios Technologies offers a comprehensive portfolio of products and services, including Symbios Tubular Plasma Reactor and TPR4000.
Energy-efficient system for oxidizing pollutants in water without chemicals.
Low-power plasma reactor for microbial and organic contamination control.
Funding Insights of Symbios Technologies
Investors in Symbios Technologies
Symbios Technologies has secured backing from 5 investors, including institutional investors. Prominent investors backing the company include DOE, National Cancer Institute and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Locked | Locked | Locked | |
|
Cancer research is conducted and supported by the institute.
|
Locked | Locked | Locked | |
|
Basic research is supported to advance medical sciences.
|
Locked | Locked | Locked |
Investor details for Symbios Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Symbios Technologies
Investment portfolio details for Symbios Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Symbios Technologies
Detailed financials for Symbios Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Symbios Technologies Comparisons
Peer comparison for Symbios Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Symbios Technologies
Symbios Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Plasma Waters, AquaPure Technologies, WaterToken, Pellucid Water and PlasmaFluids, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Plasma-activated water solutions for sustainable agriculture are provided.
|
|
| Locked | Locked | Locked |
Provides plasma-based oxidation technology for effective water treatment.
|
|
| Locked | Locked | Locked |
Develops advanced water purification systems for industrial and humanitarian applications worldwide.
|
|
| Locked | Locked | Locked |
Provides plasma-based water treatment solutions.
|
|
| Locked | Locked | Locked |
Offers plasma oxidizer systems for purifying water and liquids in various sectors.
|
Detailed competitors of Symbios Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Symbios Technologies
Complete news archive for Symbios Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Symbios Technologies
Symbios Technologies was founded in 2008 and raised its 1st funding round 3 years after it was founded.
Symbios Technologies is headquartered in Fort Collins, United States. It is registered at Fort Collins, Colorado, United States.
Aqueous plasma technology for water treatment. The offered product is called Symbios TPR4000 uses plasma-based oxidation technology which exposes water to the plasma nozzle by producing hydroxyl radicals oxidizes organic contaminants. Can remove microbes and disinfect the water without the use of chemicals. Can be used in the manufacturing, oil gas, healthcare, and the utility sector. Partners are the National Science Foundation, Colorado State University, and Advanced Energy.
Symbios Technologies's top competitors include Plasma Waters, AquaPure Technologies and WaterToken.
Symbios Technologies offers Symbios Tubular Plasma Reactor and TPR4000.
Symbios Technologies has 5 investors. Key investors include DOE, National Cancer Institute, National Science Foundation, National Institute of General Medical Sciences, and OSTI.GOV.